56 related articles for article (PubMed ID: 3720215)
1. Unique pharmacologic profile of triazolobenzodiazepines.
Lesar TS
Clin Pharm; 1986 Jun; 5(6):468-9. PubMed ID: 3720215
[No Abstract] [Full Text] [Related]
2. Benzodiazepines.
Killam EK; Suria A
Adv Neurol; 1980; 27():597-615. PubMed ID: 6990714
[No Abstract] [Full Text] [Related]
3. Pharmacologic effects of the triazolo group.
Taniguchi G
Clin Pharm; 1985; 4(3):258, 266. PubMed ID: 4006393
[No Abstract] [Full Text] [Related]
4. Synthesis and receptor binding studies of 2-functionalized 1,4-benzodiazepine derivatives as potential metaclazepam-like antianxiety agents.
Anzini M; Cappelli A; Vomero S; Cagnotto A; Skorupska M
Farmaco; 1993 Jul; 48(7):897-905. PubMed ID: 8104405
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacologic effects of tofizopam (Grandaxin)].
Petócz L
Acta Pharm Hung; 1993 Mar; 63(2):79-82. PubMed ID: 8100112
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative relationship between the structure and inhibition of thrombocyte aggregation in the arylaliphatic acid group].
Kuchar M; Rejholec V; Brůnová B; Nĕmecek O; Cepelák V
Cesk Farm; 1983 May; 32(3-4):116-21. PubMed ID: 6872011
[No Abstract] [Full Text] [Related]
7. 1,5-Benzothiazepine, a versatile pharmacophore: a review.
Bariwal JB; Upadhyay KD; Manvar AT; Trivedi JC; Singh JS; Jain KS; Shah AK
Eur J Med Chem; 2008 Nov; 43(11):2279-90. PubMed ID: 18639369
[TBL] [Abstract][Full Text] [Related]
8. [Cyclohexylphenoxymorpholines with antidepressive activity].
Carissimi M; Picciòla G; Ravenna F; Gentili P; Carenini G
Farmaco Sci; 1980 Jun; 35(6):504-26. PubMed ID: 7192648
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
10. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
Puri RN; Colman RW
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic mechanisms of action of antidepressants.
Frazer A; Conway P
Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
[TBL] [Abstract][Full Text] [Related]
12. Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists.
Keenan RM; Callahan JF; Samanen JM; Bondinell WE; Calvo RR; Chen L; DeBrosse C; Eggleston DS; Haltiwanger RC; Hwang SM; Jakas DR; Ku TW; Miller WH; Newlander KA; Nichols A; Parker MF; Southhall LS; Uzinskas I; Vasko-Moser JA; Venslavsky JW; Wong AS; Huffman WF
J Med Chem; 1999 Feb; 42(4):545-59. PubMed ID: 10052962
[TBL] [Abstract][Full Text] [Related]
13. Alboaggregins A and B. Structure and interaction with human platelets.
Kowalska MA; Tan L; Holt JC; Peng M; Karczewski J; Calvete JJ; Niewiarowski S
Thromb Haemost; 1998 Mar; 79(3):609-13. PubMed ID: 9531050
[TBL] [Abstract][Full Text] [Related]
14. Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action.
Freeman JJ; Sulser F
J Pharmacol Exp Ther; 1972 Nov; 183(2):307-15. PubMed ID: 4673401
[No Abstract] [Full Text] [Related]
15. [Variety and differences in activity of benzodiazepines (author's transl)].
Gayral LF; Picard JF; Gardes JP
Nouv Presse Med; 1982 May; 11(22):1668-73. PubMed ID: 6124932
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical, neuroautonomic and neuropharmacological acute effects of sibutramine in healthy subjects.
Lechin F; van der Dijs B; Hernandez G; Orozco B; Rodriguez S; Baez S
Neurotoxicology; 2006 Mar; 27(2):184-91. PubMed ID: 16269176
[TBL] [Abstract][Full Text] [Related]
17. The pharmacologic basis for therapeutic interest in bupropion.
Soroko FE; Maxwell RA
J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
[TBL] [Abstract][Full Text] [Related]
18. The benzodiazepine receptor: its development and its modulation by gamma-aminobutyric acid.
Regan JW; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1980 Jan; 212(1):137-43. PubMed ID: 7351621
[No Abstract] [Full Text] [Related]
19. The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents.
Hsieh PW; Hwang TL; Wu CC; Chiang SZ; Wu CI; Wu YC
Bioorg Med Chem Lett; 2007 Mar; 17(6):1812-7. PubMed ID: 17197180
[TBL] [Abstract][Full Text] [Related]
20. Specific impairment of ADP-induced platelet aggregation by cannabinoids.
Nathan I; Dvilansky A; Lazarowitz J; Lander N; Livne A
Int J Tissue React; 1986; 8(3):193-8. PubMed ID: 3781759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
